Search
for

    Glossary Isoniazid

    medication used to treat and prevent tuberculosis (TB)

    Isoniazid, also known as INH, is a medication primarily used to treat and prevent tuberculosis (TB). It works by inhibiting the synthesis of mycolic acids, which are essential components of the bacterial cell wall in Mycobacterium tuberculosis. This antibiotic is often used in combination with other TB drugs to prevent the development of drug resistance.

    Related Terms

    Research

    5 / 246 results
      Isoniazid-Induced Alopecia

      research Isoniazid-induced alopecia

      13 citations , January 2011 in “Lung India”
      This case study observed isoniazid-induced alopecia in a patient, which was confirmed as reversible since hair regrowth resumed after the drug was discontinued.
      Alopecia Caused by Isoniazid

      research Alopecia caused by isoniazid

      4 citations , April 2014 in “Journal of Pharmacology and Pharmacotherapeutics”
      This report describes a case of reversible alopecia in a 10-year-old boy attributed to isoniazid use during anti-tuberculosis therapy.
      Isoniazid-Induced Alopecia: A Rare Entity

      research Isoniazid-induced Alopecia: A Rare Entity

      November 2022 in “The Indian journal of chest diseases & allied sciences”
      This case report documents a rare instance of hair loss associated with isoniazid initiation in a 32-year-old male undergoing antitubercular treatment.

      research A Case of Valproate Toxicity Related to Isoniazid

      5 citations , November 2012 in “Journal of Clinical Psychopharmacology”
      This case report describes an 80-year-old man who developed valproate toxicity and functional decline after starting isoniazid, highlighting a potential drug interaction in elderly patients.
      Drug-Induced Acne: Causes, Diagnosis, and Treatment

      research Drug-induced acne

      52 citations , October 2016 in “Clinics in Dermatology”
      This review discusses various drugs that can cause drug-induced acne, noting specific clinical and histopathologic features, but reports no new clinical findings.